BRCA1 recruitment to damaged DNA sites is dependent on CDK9

References

• Chapman JR, Taylor MRG, Boulton SJ. Playing the end game: DNA double-strand break repair pathway choice. Mol Cell 2012; 47(4):497-510; PMID:22920291; http://dx.doi.org/10.1016/j.molcel.2012.07.029
   PubMed Web of Science ®Google Scholar
• Thompson LH. Recognition. signaling, and repair of DNA double-strand breaks produced by ionizing radiation in mammalian cells: The molecular choreography. Mutat Res 2012; 751(2):158-246; PMID:22743550; http://dx.doi.org/10.1016/j.mrrev.2012.06.002
   PubMed Web of Science ®Google Scholar
• Daley JM, Sung P. 53BP1, BRCA1, and the choice between recombination and end joining at DNA double-strand breaks. Mol Cell Biol 2014; 34(8):1380-8; PMID:24469398; http://dx.doi.org/10.1128/MCB.01639-13
   PubMed Web of Science ®Google Scholar
• Bau DT, Mau YC, Shen CY. The role of BRCA1 in non-homologous end-joining. Cancer Lett 2006; 240(1):1-8; PMID:16171943; http://dx.doi.org/10.1016/j.canlet.2005.08.003
   PubMed Web of Science ®Google Scholar
• Panier S, Boulton SJ. Double-strand break repair: 53BP1 comes into focus. Nat Rev Mol Cell Biol 2014; 15(1):7-18; PMID:24326623; http://dx.doi.org/10.1038/nrm3719
   PubMed Web of Science ®Google Scholar
• Escribano-Diaz C, Durocher D. DNA repair pathway choice–a PTIP of the hat to 53BP1. EMBO Rep 2013; 14(8):665-6; PMID:23846307; http://dx.doi.org/10.1038/embor.2013.99
   PubMed Web of Science ®Google Scholar
• Feng L, Fong KW, Wang J, Wang W, Chen J. RIF1 counteracts BRCA1-mediated end resection during DNA repair. J Biol Chem 2013; 288(16):11135-43; PMID:23486525; http://dx.doi.org/10.1074/jbc.M113.457440
   PubMed Web of Science ®Google Scholar
• Cruz-García A, López-Saavedra A, Huertas P. BRCA1 accelerates CtIP-mediated DNA-end resection. Cell Rep 2014; 9(2):451-9; PMID:25310973; http://dx.doi.org/10.1016/j.celrep.2014.08.076
   PubMed Web of Science ®Google Scholar
• Helleday T. The underlying mechanism for the PARP and BRCA synthetic lethality: clearing up the misunderstandings. Mol Oncol 2011; 5(4):387-93; PMID:21821475; http://dx.doi.org/10.1016/j.molonc.2011.07.001
   PubMed Web of Science ®Google Scholar
• Aly A, Ganesan S. BRCA1, PARP, and 53BP1: conditional synthetic lethality and synthetic viability. J Mol Cell Biol 2011; 3(1):66-74; PMID:21278454; http://dx.doi.org/10.1093/jmcb/mjq055
   PubMed Web of Science ®Google Scholar
• Baer R, Ludwig T. The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity. Curr Opin Genet Dev 2002; 12(1):86-91; PMID:11790560; http://dx.doi.org/10.1016/S0959-437X(01)00269-6
   PubMed Web of Science ®Google Scholar
• Clark SL, Rodriguez AM, Snyder RR, Hankins GD, Boehning D. Structure-function of the tumor suppressor BRCA1. Comput Struct Biotechnol J 2012; 1(1):pii: e201204005; PMID: 22737296
   PubMedGoogle Scholar
• Mesquita RD, Woods NT, Seabra-Junior ES, Monteiro AN. Tandem BRCT domains: DNA's Praetorian Guard. Genes Cancer 2010; 1(11):1140-6; PMID:21533002; http://dx.doi.org/10.1177/1947601910392988
   PubMedGoogle Scholar
• Woods NT, Mesquita RD, Sweet M, Carvalho MA, Li X, Liu Y, Nguyen H, Thomas CE, Iversen ES Jr, Marsillac S, et al. Charting the landscape of tandem BRCT domain-mediated protein interactions. Sci Signal 2012; 5(242):rs6; PMID:22990118; http://dx.doi.org/10.1126/scisignal.2002255
   PubMed Web of Science ®Google Scholar
• Cerqueira A, Santamaría D, Martínez-Pastor B, Cuadrado M, Fernández-Capetillo O, Barbacid M. Overall Cdk activity modulates the DNA damage response in mammalian cells. J Cell Biol 2009; 187(6):773-80; PMID:19995934; http://dx.doi.org/10.1083/jcb.200903033
   PubMed Web of Science ®Google Scholar
• Wohlbold L, Fisher RP. Behind the wheel and under the hood: functions of cyclin-dependent kinases in response to DNA damage. DNA Repair (Amst) 2009; 8(9):1018-24; PMID:19464967; http://dx.doi.org/10.1016/j.dnarep.2009.04.009
   PubMed Web of Science ®Google Scholar
• Price DH. P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II. Mol Cell Biol 2000; (8):2629-34; PMID:10733565; http://dx.doi.org/10.1128/MCB.20.8.2629-2634.2000
   PubMed Web of Science ®Google Scholar
• Yu DS, Zhao R, Hsu EL, Cayer J, Ye F, Guo Y, Shyr Y, Cortez D. Cyclin-dependent kinase 9-cyclin K functions in the replication stress response. EMBO Rep 2010; 11(11):876-82; PMID:20930849; http://dx.doi.org/10.1038/embor.2010.153
   PubMed Web of Science ®Google Scholar
• Zhang H, Park SH, Pantazides BG, Karpiuk O, Warren MD, Hardy CW, Duong DM, Park SJ, Kim HS, Vassilopoulos A, et al. SIRT2 directs the replication stress response through CDK9 deacetylation. Proc Natl Acad Sci U S A 2013; 110(33):13546-51; PMID:23898190; http://dx.doi.org/10.1073/pnas.1301463110
   PubMed Web of Science ®Google Scholar
• Burma S, Chen BP, Murphy M, Kurimasa A, Chen DJ. ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J Biol Chem 2001; 276(45):42462-7; PMID:11571274; http://dx.doi.org/10.1074/jbc.C100466200
   PubMed Web of Science ®Google Scholar
• Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem. 1998; 273(10):5858-68; PMID:9488723; http://dx.doi.org/10.1074/jbc.273.10.5858
   PubMed Web of Science ®Google Scholar
• Mao Z, Jiang Y, Liu X, Seluanov A, Gorbunova V. DNA repair by homologous recombination, but not by nonhomologous end joining, is elevated in breast cancer cells. Neoplasia 2009; 11(7):683-91; PMID:19568413; http://dx.doi.org/10.1593/neo.09312
   PubMed Web of Science ®Google Scholar
• Ciccia A, Elledge SJ. The DNA damage response: making it safe to play with knives. Mol Cell 2010; 40(2):179-204; PMID:20965415; http://dx.doi.org/10.1016/j.molcel.2010.09.019
   PubMed Web of Science ®Google Scholar
• Chapman JR, Sossick AJ, Boulton SJ, Jackson SP. BRCA1-associated exclusion of 53BP1 from DNA damage sites underlies temporal control of DNA repair. J Cell Sci 2012; 125(Pt 15):3529-34; PMID:22553214; http://dx.doi.org/10.1242/jcs.105353
   PubMed Web of Science ®Google Scholar
• Hu Y, Scully R, Sobhian B, Xie A, Shestakova E, Livingston DM. RAP80-directed tuning of BRCA1 homologous recombination function at ionizing radiation-induced nuclear foci. Genes Dev 2011; 25(7):685-700; PMID:21406551; http://dx.doi.org/10.1101/gad.2011011
   PubMed Web of Science ®Google Scholar
• Jeggo P, Lavin MF. Cellular radiosensitivity: how much better do we understand it? Int J Radiat Biol 2009; 85(12):1061-81
   PubMed Web of Science ®Google Scholar
• Bassing CH, Chua KF, Sekiguchi J, Suh H, Whitlow SR, Fleming JC, Monroe BC, Ciccone DN, Yan C, Vlasakova K, et al. Increased ionizing radiation sensitivity and genomic instability in the absence of histone H2AX. Proc Natl Acad Sci U S A 2002; 99(12):8173-8; PMID:12034884; http://dx.doi.org/10.1073/pnas.122228699
   PubMed Web of Science ®Google Scholar
• Lim YC, Roberts TL, Day BW, Stringer BW, Kozlov S, Fazry S, Bruce ZC, Ensbey KS, Walker DG, et al. Increased sensitivity to ionizing radiation by targeting the homologous recombination pathway in glioma initiating cells. Mol Oncol 2014; 8(8):1603-15; PMID:25017126; http://dx.doi.org/10.1016/j.molonc.2014.06.012
   PubMed Web of Science ®Google Scholar
• Savage KI, Harkin DP. BRCA1, a ‘complex’ protein involved in the maintenance of genomic stability. FEBS J 2015; 282(4):630-46; PMID:25400280; http://dx.doi.org/10.1111/febs.13150
   PubMed Web of Science ®Google Scholar
• Storch K, Cordes N. The impact of CDK9 on radiosensitivity, DNA damage repair and cell cycling of HNSCC cancer cells. Int J of Oncol 2016; 48:191-8
   PubMed Web of Science ®Google Scholar
• Laitem C, Zaborowska J, Isa NF, Kufs J, Dienstbier M, Murphy S. CDK9 inhibitors define elongation checkpoints at both ends of RNA polymerase II-transcribed genes. Nat Struct Mol Biol 2015; 22(5):396-403; PMID:25849141
   PubMed Web of Science ®Google Scholar
• Mancebo HS1, Lee G, Flygare J, Tomassini J, Luu P, Zhu Y, Peng J, Blau C, Hazuda D, Price D, Flores O. P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes Dev 1997; 11(20):2633-44; PMID:9334326; http://dx.doi.org/10.1101/gad.11.20.2633
   PubMed Web of Science ®Google Scholar
• Sato K, Sundaramoorthy E, Rajendra E, Hattori H, Jeyasekharan AD, Ayoub N, Schiess R, Aebersold R, Nishikawa H, Sedukhina AS, et al. A DNA-damage selective role for BRCA1 E3 ligase in claspin ubiquitylation, CHK1 activation, and DNA repair. Curr Biol 2012; 22(18):1659-66; PMID:22863316; http://dx.doi.org/10.1016/j.cub.2012.07.034
   PubMed Web of Science ®Google Scholar
• Densham RM, Garvin AJ, Stone HR, Strachan J, Baldock RA, Daza-Martin M, Fletcher A, Blair-Reid S, Beesley J, Johal B, et al. Human BRCA1-BARD1 ubiquitin ligase activity counteracts chromatin barriers to DNA resection. Nat Struct Mol Biol 2016; 23(7):647-55; PMID:27239795
   PubMed Web of Science ®Google Scholar
• Wu W, Nishikawa H, Fukuda T, Vittal V, Asano M, Miyoshi Y, Klevit RE, Ohta T. Interaction of BARD1 and HP1 Is Required for BRCA1 Retention at Sites of DNA Damage. Cancer Res 2015; 75(7):1311-21; PMID:25634209; http://dx.doi.org/10.1158/0008-5472.CAN-14-2796
   PubMed Web of Science ®Google Scholar
• Wu Q, Paul A, Su D, Mehmood S, Foo TK, Ochi T, Bunting EL, Xia B, Robinson CV, Wang B, Blundell TL. Structure of BRCA1-BRCT/Abraxas complex reveals phosphorylation-dependent BRCT dimerization at DNA damage sites. Mol Cell 2016; 61(3):434-48; PMID:26778126; http://dx.doi.org/10.1016/j.molcel.2015.12.017
   PubMed Web of Science ®Google Scholar
• Sy SM, Huen MS, Chen J. PALB2 is an integral component of the BRCA complex required for homologous recombination repair. Proc Natl Acad Sci U S A 2009; 106(17):7155-60; PMID:19369211; http://dx.doi.org/10.1073/pnas.0811159106
   PubMed Web of Science ®Google Scholar
• Cousineau I, Abaji C, Belmaaza A. BRCA1 regulates RAD51 function in response to DNA damage and suppresses spontaneous sister chromatid replication slippage: implications for sister chromatid cohesion, genome stability, and carcinogenesis. Cancer Res 2005; 65(24):11384-91; PMID:16357146; http://dx.doi.org/10.1158/0008-5472.CAN-05-2156
   PubMed Web of Science ®Google Scholar
• Deng CX. BRCA1 cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution. Nucleic Acids Res 2006; 34(5):1416-26; PMID:16522651; http://dx.doi.org/10.1093/nar/gkl010
   PubMed Web of Science ®Google Scholar
• Sonnenblick A, de Azambuja E, Azim HA Jr, Piccart M. An update on PARP inhibitors–moving to the adjuvant setting. Nat Rev Clin Oncol 2015; 12(1):27-41; PMID:25286972; http://dx.doi.org/10.1038/nrclinonc.2014.163
   PubMed Web of Science ®Google Scholar
• Farmer H, McCabe N, Lord CJ, Tutt AN, Johnson DA, Richardson TB, Santarosa M, Dillon KJ, Hickson I, Knights C, et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 2005; 434(7035):917-21; PMID:15829967; http://dx.doi.org/10.1038/nature03445
   PubMed Web of Science ®Google Scholar
• Longo PA, Kavran JM, Kim MS, Leahy DJ. Transient mammalian cell transfection with polyethylenimine (PEI). Methods Enzymol 2013; 529:227-40; PMID:24011049
   PubMed Web of Science ®Google Scholar
• GE Healthcare Life Sciences. GST Gene Fusion System Handbook. 2002. Available at: http://docplayer.net/147913-Ge-healthcare-life-sciences-gst-gene-fusion-system-handbook-imagination-at-work.html
   Google Scholar
• Carvalho RS, Fernandes VC, Nepomuceno TC, Rodrigues DC, Woods NT, Suarez-Kurtz G, Chammas R, Monteiro AN, Carvalho MA. Characterization of LGALS3 (galectin-3) as a player in DNA damage response. Cancer Biol Ther 2014; 15(7):840-50; PMID:24755837; http://dx.doi.org/10.4161/cbt.28873
   PubMed Web of Science ®Google Scholar
• Velkova A, Carvalho MA, Johnson JO, Tavtigian SV, Monteiro AN. Identification of Filamin A as a BRCA1-interacting protein required for efficient DNA repair. Cell Cycle 2010; 9(7):1421-33; PMID:20305393; http://dx.doi.org/10.4161/cc.9.7.11256
   PubMed Web of Science ®Google Scholar